Klinische Wochenschrift

, Volume 64, Issue 14, pp 663–665 | Cite as

Hodgkinsche Erkrankung nach Nierentransplantation unter Cyclosporin A

  • K. Görg
  • C. Görg
  • K. Havemann
  • H. Lange
Kasuistik

Hodgkin's disease after kidney transplantation and immunosuppressive therapy

Summary

A 44-year-old patient with polycystic kidney disease received a renal transplant in December 1984. Nine months after immunosuppressive therapy with cyclosporin A and prednisolone the patient developed Hodgkin's disease of the mediastinum.

Key words

Hodgkin's disease Cyclosporin A Kidney transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Armstrong MYK, Ruddle NM, Lipman MP et al. (1973) Tumor induction by immunologically activated murine leukemia virus. J exp Med 137:1163Google Scholar
  2. 2.
    Balls M, Ruben LN (1968) Lymphoid tumors in amphibia: a review. Prog exp Tumor Res 10:238Google Scholar
  3. 3.
    Birkeland SA (1983) Malignant tumor in renal transplant patients. The scandia transplant material. Cancer 51:1571Google Scholar
  4. 4.
    Canadian Multicentre Transplant Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. J Engl J Med 309:809Google Scholar
  5. 5.
    Cerilli J, Rynosiewicz J, Lenos L et al. (1977) Hodgkin's disease in human renal transplantation. Am J Surg 133:182Google Scholar
  6. 6.
    Doyle TJ, Venkatachalam Kumarapuram K et al. (1983) Hodgkin's disease in renal transplant recipients. Cancer 51:245Google Scholar
  7. 7.
    Gleichmann E, Gleichmann H, Schwartz RS et al. (1975) Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model. J Natl Cancer Inst 54:107Google Scholar
  8. 8.
    Graffenried B, Krupp P (1985) Nebenwirkungen von Ciclosporin nach Nierentransplantation und bei Patienten mit Autoimmunerkrankungen. Internist 26:542Google Scholar
  9. 9.
    Hirsch MS, Proffitt MR, Black PH (1977) Autoimmunity, oncornaviruses and lymphomagenesis. Contemp Top Immunobiol 6:209Google Scholar
  10. 10.
    Jacobs C, Brunner FP, Brynger M et al. (1981) Malignant diseases in patients treated by dialysis and transplantation in Europe. Transplant Proc 13:729Google Scholar
  11. 11.
    Kinlen LJ, Sheil AGR, Peto J et al. (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Brit Med J 2:1461Google Scholar
  12. 12.
    Metcalf D (1963) Induction of reticular tumors in mice by repeated antigenic stimulation. Acta Univ Int Contra Cancruv 19:657Google Scholar
  13. 13.
    Penn I (1978a) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492Google Scholar
  14. 14.
    Penn I (1978b) Tumors arising in organ transplant recipients. Advances Cancer Res 28:31Google Scholar
  15. 15.
    Penn I (1980b) Some contributions of transplantation to our knowledge of cancer. Transplant Proc 12:676Google Scholar
  16. 16.
    Penn I (1981a) Malignant lymphomas in organ transplant recipients. Transplant Proc 13:736Google Scholar
  17. 17.
    Penn I (1981) Depressed immunity and the development of cancer. Clin exp Immunol 46:459Google Scholar
  18. 18.
    Pertilo DT (1980) Epstein Barr-virus induced oncogenesis in immun-deficient individuals. Lancet I:300Google Scholar
  19. 19.
    Schwartz RS (1980) Epstein Barr-virus oncogen or mitogen? (Editorial) N Engl J Med 302:1307Google Scholar
  20. 20.
    Sterling W, Wu L, Dowling E (1974) Hodgkin's disease in renal transplant recipients. Transplantation 75:315Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • K. Görg
    • 1
  • C. Görg
    • 1
  • K. Havemann
    • 1
  • H. Lange
    • 2
  1. 1.Abteilung Hämatologie/Onkologie am Zentrum für Innere MedizinMarburg
  2. 2.Abteilung für Nephrologie am Zentrum für Innere MedizinMarburg

Personalised recommendations